Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations

Mingyan Zhou1, Haichuan Duan, Karen Engel

  • 1University of Washington, Health Sciences Building, Seattle, WA 98195-7610, USA.

Insights

The plasma membrane monoamine transporter (PMAT) transports adenosine but prefers organic cations. This study clarifies PMAT

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The plasma membrane monoamine transporter (PMAT), also known as solute carrier 29A4, is characterized as a polyspecific organic cation transporter.
  • Recent findings suggested PMAT might also transport nucleosides, proposing a dual function.
  • Clarifying PMAT's substrate specificity is crucial for understanding its physiological and pharmacological roles.

Purpose of the Study:

  • To comprehensively analyze the substrate specificity of human PMAT for nucleosides, nucleobases, and organic cations.
  • To determine if PMAT functions as a dual nucleoside/organic cation transporter or primarily as an organic cation transporter.
  • To elucidate the kinetic properties and pH-dependence of PMAT-mediated transport.

Main Methods:

  • Utilized heterologous expression systems to study human PMAT transport activity.
  • Tested transport of 12 naturally occurring nucleosides and nucleobases, alongside known organic cation substrates.
  • Performed kinetic analyses (Vmax, Km) and assessed pH and membrane potential sensitivity.

Main Results:

  • PMAT significantly transported only adenosine among the tested nucleosides and nucleobases.
  • Adenosine transport by PMAT was saturable, pH-dependent, and membrane-potential sensitive.
  • PMAT exhibited at least 10-fold lower transport efficiency for adenosine compared to organic cations like MPP+ and serotonin, with acidic pH enhancing uptake for both substrate types.

Conclusions:

  • PMAT demonstrates a clear kinetic preference for organic cation substrates over adenosine.
  • While PMAT can transport adenosine, it functions predominantly as a polyspecific organic cation transporter.
  • The findings necessitate a re-evaluation of PMAT's classification and functional role in cellular transport.

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...